tachyplesin manufacturers
- Tachyplesin I
-
-
2026-08-25
- CAS:118231-04-2
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: 20 tons
|
| | tachyplesin Basic information |
| Product Name: | tachyplesin | | Synonyms: | tachyplesin;Tachyplesin peptide, Tachypleus tridentatus;L-Argininamide, L-lysyl-L-tryptophyl-L-cysteinyl-L-phenylalanyl-L-arginyl-L-valyl-L-cysteinyl-L-tyrosyl-L-arginylglycyl-L-isoleucyl-L-cysteinyl-L-tyrosyl-L-arginyl-L-arginyl-L-cysteinyl-, cyclic (3→16),(7→12)-bis(disulfide);Tachyplesin I (9CI);Tachyplesin I trifluoroacetate | | CAS: | 118231-04-2 | | MF: | C99H151N35O19S4 | | MW: | 2263.75 | | EINECS: | | | Product Categories: | | | Mol File: | 118231-04-2.mol |  |
| | tachyplesin Chemical Properties |
| density | 1.533±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | form | Solid | | color | White to off-white | | Sequence | Lys-Trp-Cys-Phe-Arg-Val-Cys-Tyr-Arg-Gly-Ile-Cys-Tyr-Arg-Arg-Cys-Arg-NH2 (Disulfide bridge:Cys3-Cys16,Cys7-Cys12) |
| | tachyplesin Usage And Synthesis |
| Uses | Tachyplesin I is a β-hairpin antimicrobial peptide that contains 17 amino acid residues. Tachyplesin I exhibits cytotoxic properties against various human tumor cell lines acting primarily by impairing the integrity of the outer cell membrane[1]. | | References | [1] D V Kuzmin, et al. In Vitro Study of Antitumor Effect of Antimicrobial Peptide Tachyplesin I in Combination with Cisplatin. Bull Exp Biol Med. 2018 Jun;165(2):220-224. DOI:10.1007/s10517-018-4134-6 |
| | tachyplesin Preparation Products And Raw materials |
|